Skip to main content

Table 2 Factors of hemostasis and endothelial dysfunction in men with coronary atherosclerosis (M ± σ)

From: Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis

Factors of hemostasis and endothelial dysfunction in the blood Men (n = 54) with stable plaques in the coronary arteries Men (n = 63) with vulnerable plaques in the coronary arteries p
Factor II, µg/ml 252.1 ± 50.9 260.1 ± 58.9 0.474
Factor VII, ng/ml 422.0 ± 147.5 590.1 ± 150.1* 0.016
Factor XII, µg/ml 84.8 ± 58.1 119.9 ± 55.2* 0.010
Antithrombin III, µg/ml 610.9 ± 165.5 600.4 ± 209.6 0.851
Homocystein, µmol/l 18.2 ± 5.2 18.4 ± 8.1 0.626
MCP-1, pg/ml 525.7 ± 188.8 956.8 ± 501.8* 0.015
Endothelin-1, pmol/l 0.8 ± 0.6 1.3 ± 0.6 0.844
ADMA, µmol/l 1.4 ± 0.5 1.4 ± 0.7 0.821
PAI-1, ng/ml 397.5 ± 129.3 399.8 ± 136.5 0.855
sVCAM-1, ng/ml 1017.6 ± 521.8 716.5 ± 345.6* 0.025
  1. *p<0.05